Concepedia

Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions

Mary Jeanne Kreek, James H. Schluger, L.A.H. Borg, Mithat Gunduz, A. Ho

Journal of Pharmacology and Experimental Therapeutics · 1999 · 91 citations · 36 references

References

36

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

Charles Chavkin, Iain F. James, Avram Goldstein · Science · 1982 · 1.2K citations

Medicine, Medicinal Chemistry, Pharmacology +17

Psychopharmacology: The Fourth Generation of Progress

Alan I. Green · Psychiatric Services · 1996 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +8

Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Alan Goldstein, Shizuko Tachibana, Louise I. Lowney et al. · Proceedings of the National Academy of Sciences · 1979 · 870 citations · Full text

Medicine, Neurobiology, Pharmacology +15

The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study

Rainer Spanagel, Albert Herz, Toni S. Shippenberg · Journal of Neurochemistry · 1990 · 541 citations

Medicine, Neuroscience, Pharmacology +17

Kappa–opioids produce significantly greater analgesia in women than in men

Robert W. Gear, Christine Miaskowski, Newton C. Gordon et al. · Nature Medicine · 1996 · 456 citations

Medicine, Anesthesiology, Pharmacology +13